2.1.2.5 Patients receiving any medications that are known to be strong inducers or inhibitors of CYP3A4, or sensitive substrates of CYP3A4, CYP1A2, CYP2C9, CYP2C9, CYP2C19 or P-gp with a narrow therapeutic index.